Coronary Stent Market Overview
The global Coronary Stent market was valued at USD 9.0 billion in 2024 and is expected to grow from USD 9.5 billion in 2025 to USD 14.5 billion by 2035, registering a CAGR of 5.2% during the forecast period from 2026 to 2035. Rising prevalence of coronary artery disease, increasing cardiovascular disease burden, growing adoption of minimally invasive interventions, and advances in stent technologies are supporting market expansion.
North America is expected to remain the leading regional market, supported by advanced cardiovascular-care infrastructure and the high adoption of percutaneous coronary intervention procedures. Among product types, drug-eluting stents represent a major segment because of their ability to reduce restenosis following coronary intervention. Growing demand for newer-generation stents with improved flexibility, deliverability, and biocompatibility is also contributing to market development.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/reports/coronary-stent-market
Key Companies in the Coronary Stent Market
Abbott Laboratories
Boston Scientific Corporation
Medtronic plc
Johnson & Johnson
B. Braun Melsungen AG
MicroPort Scientific Corporation
Terumo Corporation
Biotronik SE & Co. KG
Meril Life Sciences
Lepu Medical Technology
Biosensors International Group
Stryker Corporation
Transluminal Technologies
Vascular Concepts
The market is being driven by the increasing prevalence of cardiovascular diseases and the growing number of patients requiring coronary interventions. An aging population, sedentary lifestyles, obesity, diabetes, and hypertension are contributing to the burden of coronary artery disease. Technological advances in drug-eluting stents, biodegradable polymers, bioresorbable stents, and improved delivery systems are helping enhance procedural outcomes and expand treatment options.
The Coronary Stent Market is segmented by stent type, material, design, application, and end user. Stent types include drug-eluting stents, bare-metal stents, and bioresorbable stents. Materials include cobalt-chromium, platinum-chromium, stainless steel, and other advanced alloys. Applications cover coronary artery disease, acute myocardial infarction, and other cardiovascular conditions, while end users include hospitals, cardiac centers, and ambulatory surgical centers.
Recent Developments and Market Trends:
Drug-eluting stents continue to dominate the market because of their ability to reduce restenosis and improve long-term outcomes after coronary intervention.
New-generation stents are increasingly designed with thinner struts, improved flexibility, and enhanced deliverability to support complex coronary procedures.
Bioresorbable and biodegradable-polymer technologies are receiving increased attention because they are designed to reduce long-term foreign-body exposure.
Advances in imaging and catheter technologies are improving stent placement accuracy and procedural outcomes.
The growing adoption of minimally invasive cardiovascular interventions is increasing demand for coronary stents across hospitals and specialized cardiac centers.
Emerging markets in Asia Pacific are creating additional opportunities as cardiovascular disease prevalence increases and access to interventional cardiology improves.
Reasons to Buy the Report:
Understand the current market size, growth trajectory, and forecast of the global Coronary Stent Market through 2035.
Analyze key segments based on stent type, material, design, application, end user, and region.
Evaluate regional opportunities across North America, Europe, Asia Pacific, South America, and the Middle East and Africa.
Identify major companies and understand their competitive positioning in the coronary stent industry.
Assess the impact of cardiovascular disease prevalence, minimally invasive procedures, technological innovation, and healthcare infrastructure on market growth.
Understand emerging opportunities associated with drug-eluting stents, bioresorbable technologies, advanced materials, and improved delivery systems.
Future Outlook:
The global Coronary Stent Market is expected to maintain steady growth through 2035 as cardiovascular disease continues to create significant demand for interventional treatment. Increasing adoption of minimally invasive procedures, improvements in drug-eluting stents, advanced biomaterials, and next-generation delivery systems are expected to support market expansion. Growing cardiovascular-care investments in emerging economies and continued innovation in stent design are likely to create additional opportunities for manufacturers and healthcare providers.
➤➤Explore Our Latest Related Reports:
